April L. Goley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
April L. Goley has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Bonnie Alexander
Department of Medicine, University of North Carolina Medical Center, Chapel Hill, NC 27514, USA
1 shared publication - Emily Stevenson
Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC 27514, USA
1 shared publication - Joanna Ma
Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC 27514, USA
1 shared publication - Kristen R. Szempruch
Department of Pharmacy University of North Carolina Medical Center Chapel Hill North Carolina USA
1 shared publication - Mary M. Chandran
Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC 27514, USA
1 shared publication - Rachel Bassett Allen
UNC Medical Center Chapel Hill North Carolina USA
1 shared publication
Latest Publications
- Open Access
- 11 October 2025
- Published by MDPI AG in Transplantology
- Vol. 6 (4) , 30
Should Early Hyperglycemia Be Considered a Risk Factor for Post-Transplant Diabetes Mellitus? Findings from a Retrospective Cohort Study in Kidney Transplant Recipients Without Diabetes Mellitus Prior to Transplant
Background: Post-transplant diabetes mellitus (PTDM) is a complication of kidney transplantation, but the impact of early hyperglycemia (EH) remains unclear. This study aimed to assess the incidence of PTDM in kidney transplant recipients (KTRs) who experienced EH compared to those who do not at 6 months post-transplant. Methods: A single-center, retrospective cohort study was conducted in adults who underwent kidney transplantation from 1 January 2019 to 25 May 2022. KTRs who developed EH were compared against those who did not. Results: The primary outcome was the difference in incidence of PTDM at 6 months. Secondary outcomes included rehospitalizations and infections within 6 months and PTDM, renal function, cardiovascular events, and graft and patient survival within 12 months. Two hundred and seventy-nine KTRs (EH, n = 204 vs. comparator, n = 75) were included. There were higher incidences of PTDM in the EH group compared to the comparator group at 6 months (11% vs. 1.4%, p = 0.012) and 12 months post-transplant (18.5% vs. 5.5%, p = 0.007). KTRs with EH had 8.9 times greater odds of developing PTDM (OR 8.9; 95% 1.2–67.3, p = 0.03) at 6 months. There was no significant difference found in other secondary outcomes. Conclusions: KTRs with EH had an increased incidence of developing PTDM.
- 11 October 2025
- Published by MDPI AG in Transplantology
- Vol. 6 (4) , 30
Open AccessShould Early Hyperglycemia Be Considered a Risk Factor for Post-Transplant Diabetes Mellitus? Findings from a Retrospective Cohort Study in Kidney Transplant Recipients Without Diabetes Mellitus Prior to Transplant
Background: Post-transplant diabetes mellitus (PTDM) is a complication of kidney transplantation, but the impact of early hyperglycemia (EH) remains unclear. This study aimed to assess the incidence of PTDM in kidney transplant recipients (KTRs) who experienced EH compared to those who do not at 6 months post-transplant. Methods: A single-center, retrospective cohort study was conducted in adults who underwent kidney transplantation from 1 January 2019 to 25 May 2022. KTRs who developed EH were compared against those who did not. Results: The primary outcome was the difference in incidence of PTDM at 6 months. Secondary outcomes included rehospitalizations and infections within 6 months and PTDM, renal function, cardiovascular events, and graft and patient survival within 12 months. Two hundred and seventy-nine KTRs (EH, n = 204 vs. comparator, n = 75) were included. There were higher incidences of PTDM in the EH group compared to the comparator group at 6 months (11% vs. 1.4%, p = 0.012) and 12 months post-transplant (18.5% vs. 5.5%, p = 0.007). KTRs with EH had 8.9 times greater odds of developing PTDM (OR 8.9; 95% 1.2–67.3, p = 0.03) at 6 months. There was no significant difference found in other secondary outcomes. Conclusions: KTRs with EH had an increased incidence of developing PTDM.